Clinical Trials Directory

Trials / Completed

CompletedNCT01707615

Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Atherosclerotic Plaques in Clinical Use

Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Carotid Intima-media Thickness and Atherosclerotic Plaques in Clinical Use

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
287 (actual)
Sponsor
Jie Qiu · Academic / Other
Sex
All
Age
43 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the antiatherogenic effect of GSPE in clinical use

Detailed description

Atherosclerotic plaques indicate the occurrence of ischemia events and how to deal with it is a difficult task for clinical physicians. Grape seed proanthocyanidin extrat (GSPE) has been reported to exert an antiatherogenic effect by inducing regression of atherosclerotic plaques in animal experimental studies. In this study, the antiatherogenic effect of GSPE has been investigated in clinical use.

Conditions

Interventions

TypeNameDescription
DRUGGSPEGSPE 240 mg/day (120mg bid)
OTHERlifestyle interventiondietary modification making the total ingestion of calories into standard body weight 25 kCal in effect and an individualized home exercise program of a minimum 150 min/week of moderate-intensity physical activity

Timeline

Start date
2006-10-01
Primary completion
2011-09-01
Completion
2011-10-01
First posted
2012-10-16
Last updated
2012-10-16

Source: ClinicalTrials.gov record NCT01707615. Inclusion in this directory is not an endorsement.